Justin Roberts

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tunable endogenous protein degradation with heterobifunctional comp...
- Patent number 12,023,385
- Issue date Jul 2, 2024
- Dana-Farber Cancer Institute, Inc.
- Dennis Buckley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulating chimeric antigen receptors
- Patent number 11,311,609
- Issue date Apr 26, 2022
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tunable endogenous protein degradation
- Patent number 11,293,023
- Issue date Apr 5, 2022
- Dana-Farber Cancer Institute, Inc.
- Dennis Buckley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted protein degradation to attenuate adoptive T-cell therapy a...
- Patent number 11,046,954
- Issue date Jun 29, 2021
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bivalent bromodomain inhibitors and uses thereof
- Patent number 10,913,752
- Issue date Feb 9, 2021
- Dana-Farber Cancer Institute, Inc.
- James E. Bradner
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TUNABLE ENDOGENOUS PROTEIN DEGRADATION
- Publication number 20220135967
- Publication date May 5, 2022
- Dana-Farber Cancer Institute, Inc.
- Dennis Buckley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
- Publication number 20220119416
- Publication date Apr 21, 2022
- Dana-Farber Cancer Institute, Inc.
- James E. Bradner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY A...
- Publication number 20210301286
- Publication date Sep 30, 2021
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
- Publication number 20210221826
- Publication date Jul 22, 2021
- Dana-Farber Cancer Institute, Inc.
- James E. Bradner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
- Publication number 20200172553
- Publication date Jun 4, 2020
- Dana-Farber Cancer Institute, Inc.
- James E. Bradner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUNABLE ENDOGENOUS PROTEIN DEGRADATION WITH HETEROBIFUNCTIONAL COMP...
- Publication number 20190374657
- Publication date Dec 12, 2019
- Dana-Farber Cancer Institute, Inc.
- Dennis Buckley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
REGULATING CHIMERIC ANTIGEN RECEPTORS
- Publication number 20190365875
- Publication date Dec 5, 2019
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF
- Publication number 20180354973
- Publication date Dec 13, 2018
- Dana-Farber Cancer Institute, Inc.
- James E. Bradner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUNABLE ENDOGENOUS PROTEIN DEGRADATION
- Publication number 20180179522
- Publication date Jun 28, 2018
- Dana-Farber Cancer Institute, Inc.
- Dennis Buckley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY A...
- Publication number 20180169109
- Publication date Jun 21, 2018
- Dana-Farber Cancer Institute, Inc.
- James Bradner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Justin Roberts

Person

Patents Grantslast 30 patents

Tunable endogenous protein degradation with heterobifunctional comp...

Regulating chimeric antigen receptors

Tunable endogenous protein degradation

Targeted protein degradation to attenuate adoptive T-cell therapy a...

Bivalent bromodomain inhibitors and uses thereof

Patents Applicationslast 30 patents

TUNABLE ENDOGENOUS PROTEIN DEGRADATION

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY A...

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

TUNABLE ENDOGENOUS PROTEIN DEGRADATION WITH HETEROBIFUNCTIONAL COMP...

REGULATING CHIMERIC ANTIGEN RECEPTORS

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

TUNABLE ENDOGENOUS PROTEIN DEGRADATION

TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY A...